at IsoPlexis
We seek top talent to help us lead the fight against cancer and eradicate the world’s toughest diseases
IsoPlexis is dedicated to accelerating the fight against cancer and a range of the world’s toughest diseases with our uniquely correlative, award-winning single-cell detection systems.
By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise & personalized stage. Our integrated systems, named #1 innovation by the Scientist Magazine & Fierce, are used globally to advance the field of single-cell biology and biomarkers as we generate solutions to overcome the challenges of complex diseases.
- We make decisions based on data, and lots of it
- We prize publishing and communicating data that will rapidly advance personalized, curative medicines
- We make decisions based on data, and lots of it
- We prize publishing and communicating data that will rapidly advance personalized, curative medicines
- We make decisions based on data, and lots of it
- We prize publishing and communicating data that will rapidly advance personalized, curative medicines
Cutting edge biology and engineering. Turning scientific promise into reality.
